Abstract

There are over 70.000 patients with cystic fibrosis (CF) in the world and numerous sequence variations in the CFTR gene have been reported but the clinical significance of all of them is still not known. There are currently 195 patients with the c.3140-26A>G (legacy name 3272-26A>G) variant in the CFTR gene listed in the European Cystic Fibrosis Society Patient Registry (ECFSPR) and only 4 are homozygous. We present longitudinal clinical data of one of these patients who is managed in our CF Center at the University Children's Hospital in Ljubljana and compare it with the patient data from the ECFSPR and the CFTR2 database in which additional 3 homozygous patients are described. Moreover, the effect of the detected variant in the described patient was evaluated on the RNA level in nasal epithelial cells. The variant was shown to result in aberrant splicing introducing a frameshift and a premature termination codon while normal transcript was not detected. Alternative spliced mutant transcripts in other tissues or the presence of spliceosome-mediated RNA trans-splicing could explain the mild clinical presentation of patients with this variant in homozygous state.

Highlights

  • IntroductionCystic fibrosis (CF) is one of the most common inherited diseases in Caucasians

  • There are over 70.000 patients with cystic fibrosis (CF) in the world and numerous sequence variations in the CFTR gene have been reported but the clinical significance of all of them is still not known

  • There are currently 195 patients with the c.3140-26A>G variant in the CFTR gene listed in the European Cystic Fibrosis Society Patient Registry (ECFSPR) and only 4 are homozygous

Read more

Summary

Introduction

Cystic fibrosis (CF) is one of the most common inherited diseases in Caucasians. The incidence of the disease differs between populations with the highest incidence in Ireland 1:1.800 and the lowest in Finland with 1:20.000.1 The incidence of CF in Slovenia is 1:4.500.2 CF affects many organs. The lungs, gastrointestinal system, pancreas, liver, nose and sweat glands are most commonly involved. In 1989 the CFTR gene was discovered and variants of this gene were shown to be causative of CF.[3] In 2016 De Boeck and Amaral[4] updated the 1995 Zielinski and Tsui[5] classification of CFTR variants from 5 classes to 7 according to the mechanism by which they disrupt the synthesis, trafficking and function of the CFTR protein

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call